Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025 Pastilles have overtaken oil as the second-most prescribed dosage form for medicinal cannabis through the Special […]
InhaleRx locks in A$1m cap raise and reveals plans to rebrand by Adam Sheldon December 1, 2025February 21, 2026
Biortica formally ends RTO bid and targets ASX listing in early 2026 by Steve Jones November 27, 2025December 4, 2025
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
Medicinal cannabis works. What’s broken is the culture around it by Dr Afraz Adams November 27, 2025November 27, 2025
Debt-laden Cannim poised for liquidation as potential buyers walk away by Steve Jones November 27, 2025December 2, 2025
Women are cannabis reform’s ‘greatest untapped potential’ by Adam Sheldon November 26, 2025November 27, 2025
Compliance gaps, slow licensing and strict rules put Australia at risk on global stage, expert warns by Adam Sheldon November 26, 2025November 26, 2025
Vitura survey reveals 54% of young adults used GP telehealth in the past year by Adam Sheldon November 25, 2025February 21, 2026
